Cardiol Therapeutics
(NASDAQ:CRDL)
$2.14
0[0.00%]
Last update: 9:24AM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Cardiol Therapeutics Stock (NASDAQ:CRDL), Quotes and News Summary

Cardiol Therapeutics Stock (NASDAQ: CRDL) stock price, news, charts, stock research, profile.

Open$2.160
Close-
Volume / Avg.205.120K / 408.901K
Day Range2.140 - 2.210
52 Wk Range0.550 - 2.240
Market Cap$146.095M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
64
Short Interest
0.42%
Days to Cover1.09

Recent News

Sponsored
Cardiol Therapeutics Fights Heart Inflammation With Novel Formulations
697,000 people die from heart disease every year in the United States – that is one in every five deaths.
CBD To Treat Heart Failure? New Study Shows Its Cardioprotective Effects
On Tuesday, Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) announced positive study results demonstrating that subcutaneously administered cannabidiol - the active pharmaceutical ingredient in Cardiol's novel CRD-38 subcutaneous (SUBQ) formulati
Jelena Martinovic
Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Gainers Near Intelligence, Inc. (NASDAQ: NIR) shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesday. Near Intelligence recently named its General Counsel, Jay Angelo, to also serve as the company’s Chief Privacy Officer.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CRDL

FAQ

Q

How do I buy Cardiol Therapeutics (CRDL) stock?

A

You can purchase shares of Cardiol Therapeutics (NASDAQ: CRDL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cardiol Therapeutics's (CRDL) competitors?

A

There are no as such competitors for Cardiol Therapeutics.

Q

What is the target price for Cardiol Therapeutics (CRDL) stock?

A

The latest price target for Cardiol Therapeutics (NASDAQ: CRDL) was reported by HC Wainwright & Co. on Monday, April 22, 2024. The analyst firm set a price target for 9.00 expecting CRDL to rise to within 12 months (a possible 314.27% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cardiol Therapeutics (CRDL)?

A

The stock price for Cardiol Therapeutics (NASDAQ: CRDL) is $2.1725 last updated Today at May 13, 2024 at 3:31 PM EDT.

Q

Does Cardiol Therapeutics (CRDL) pay a dividend?

A

There are no upcoming dividends for Cardiol Therapeutics.

Q

When is Cardiol Therapeutics (NASDAQ:CRDL) reporting earnings?

A

Cardiol Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Q

Is Cardiol Therapeutics (CRDL) going to split?

A

There is no upcoming split for Cardiol Therapeutics.

Q

What sector and industry does Cardiol Therapeutics (CRDL) operate in?

A

Cardiol Therapeutics is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.